Regulation of protein metabolism

Handbook of Neurochemistry and Molecular Neurobiology: Neural Protein Metabolism and Function

Volumn , Issue , 2007, Pages 1-33

  Salinas, M ^a   Burda, J ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955559238     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-30379-6_1     Document Type: Chapter

References (246)

1. Alcázar A, Martín ME, Soria E, Rodrìguez S, Fando JL, et al. 1995. Purification and characterization of guanine nucleotide-exchange factor, eIF-2B, and p37 calmodulin-binding protein from calf brain. J Neurochem 65:754-761.
2. Alirezaei M, Marin P, Nairn AC, Glowinski J, Prémont J. 2001. Inhibition of protein synthesis in cortical neurons during exposuretohydrogen peroxide. J Neurochem 76:1080-1088.
3. Althausen S, Mengesdorf T, Mies G, Oláh L, Nairn AC, et al. 2001. Changes in the phosphorylation of initiation factor eIF-2α, elongation factor eEF-2, and p70 S6 kinase after transient focal cerebral ischemia in mice. J Neurochem 78:779-787.
4. Andersen GR, Nissen P, Nyborg J. 2003. Elongation factors in protein biosynthesis. Trends Biochem Sci 28:434-441.
5. Araki T, Kato H, Inoue T, Kogure K. 1990. Regional impairment of protein synthesis following brief cerebral ischemia in the gerbil. Acta Neuropathol 79:501-505.
6. Asaki C, Usuda N, Nakazawa A, Kametani K, Suzuki T. 2003. Localization of translational components at the ultramicroscopic level at postsynaptic sites of the rat brain. Brain Res 972:168-176.
7. Atkins CM, Nozaki N, Shigeri Y, Soderling TR. 2004. Cytoplasmic polyadenylation element binding proteindependent protein synthesis is regulated by calcium/calmodulin-dependent protein kinase II. J Neurosci 24:5193-5201.
8. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, et al. 2004. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5:553-563.
9. Banko JL. Hou L, Klann E. 2004. NMDA receptor activation results in PKA- and ERK-dependent Mnk1 activation and increased eIF4E phosphorylation in hippocampal area CA1. J Neurochem 91:462-470.
10. Barone FC, White RF, Spera PA, Ellison J, Currie RW, et al. 1998. Ischemic preconditioning and brain tolerance. Temporal, histological, and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29:1937-1951.
11. Bear MF, Kimberly MH, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci 27:370-377.
12. Belsham GJ, Jackson RJ. 2000. Translation initiation on picornavirus RNA. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 869-900.
13. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15:658-664.
14. Berlanga JJ, Santoyo J, de Haro C. 1999. Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2α kinase. Eur J Biochem 265:754-762.
15. Blais JD, Filipenko V, Bi M, Harding HP, Ron D, et al. 2004. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol 24:7469-7482.
16. Brostrom CO, Brostrom MA. 1998. Regulation of translational initiation during cellular responses to stress. Prog Nucleic Acid Res 58:79-125.
17. Brostrom MA, Brostrom CO. 2003. Calcium dynamics and endoplasmic reticular function in the regulation of protein synthesis: Implications for cell growth and adaptability. Cell Calcium 34:345-363.
18. Browing KS, Gallie DR, Hersey JWB, Hinnebusch AG, Maitra U, et al. 2001. Unified nomenclature for the subunits of eukaryotic initiation factor 3. Trends Biochem Sci 26:284.
19. Browne GJ, Proud CG. 2002. Regulation of peptidechain elongation in mammalian cells. Eur J Biochem 269:5360-5368.
20. * to the endoplasmic reticulum and promotes dephosphorylation of the a subunit of eukaryotic translation initiation factor 2. Mol Cell Biol 23:1292-1303.
21. Burda J, Chavko M, Marsala J. 1980. Changes in ribosomes from ischemic spinal cord. Collect Czech Chem Commun 45:2566-2571.
22. Burda J, Hrehorovská M, Garcia L, Danielisova V, Cízková D, et al. 2003. Role of protein synthesis in the ischemic tolerance acquisition induced by transient forebrain ischemia in the rat. Neurochem Res 28:1237-1243.
23. Burda J, Martín ME, García A, Alcázar A, Fando JL, et al. 1994. Phosphorylation of the a subunit of initiation factor 2 correlates with the inhibition of translation following transient cerebral ischemia in the rat. Biochem J 302:335-338.
24. Burda J, Martín ME, Gottlieb M, Chavko M, Marsala J, et al. 1998. The intraischemic and early reperfusion changes of protein synthesis in the rat brain. eIF-2α kinase activity and role of initiation factors eIF-2α and eIF-4E. J Cereb Blood Flow Metab 18:59-66.
25. Bushell M, McKendrick L, Jänicke RU, Clemens MJ, Morley SJ. 1999. Caspase-3 is necessary and sufficient for cleavage of protein synthesis eukaryotic initiation factor 4G during apoptosis. FEBS Lett 451:332-336.
26. Bushell M, Wood W, Clemens MJ, Morley SJ. 2000. Changes in integrity and association of eukaryotic protein synthesis initiation factors during apoptosis. Eur J Biochem 267:1083-1091.
27. Caldarola S, Amaldi F, Proud CG, Loreni F. 2004. Translational regulation of terminal oligopyrimidine mRNAs induced by serum and amino acids involves distinct signaling events. J Biol Chem 279:13522-13531.
28. Calderon A, Jover T, Noh K, Tanaka H, Yokota H, et al. 2003. Ischemic insults derepress the gene silencer REST in neurons destined to die. J Neurosci 23:2112-2121.
29. Calés C, Salinas M, Fando JL. 1985. Isolation of eukaryotic initiation factor 2 from rat brain. J Neurochem 45:1298-1302.
30. Carter MS, Kuhn KM, Sarnow P. 2000. Cellular internal ribosome entry site elements and the use of cDNA microarrays in their investigation. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 615-635.
31. Chan PH. 1996. Role of oxidants in ischemic brain damage. Stroke 27:1124-1129.
32. Chen J-J. 2000. Heme-regulated eIF2α kinase. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 529-546.
33. Choi DW. 1990. Limitations of in vitro models of ischemia. Current and future trends in anticonvulsant, anxiety, and stroke therapy. Meldrum BS, Williams M, editors. New York: Wiley-Liss; pp. 291-299.
34. Clemens MJ. 1999. Translational Control: The cancer connection. Int J Biochem Cell Biol 31:1-254.
35. Clemens MJ. 2001. Initiation factor eIF2α phosphorylation in stress responses and apoptosis. Prog Mol Subcell Biol 27:57-89.
36. Coller J, Parker R. 2004. Eukaryotic mRNA decapping. Annu Rev Biochem 73:861-890.
37. Colthurst DR, Campbell DG, Proud CG. 1987. Structure and regulation of eukaryotic initiation factor eIF-2. Sequence of the site in the a subunit phosphorylated by the hemecontrolled repressor and by the double-stranded RNA-activated inhibitor. Eur J Biochem 166:357-363.
38. Cooper HK, Zaleswska T, Kawakami S, Hossmann KA, Kleihues P. 1977. The effect of ischemia and recirculation on protein synthesis in the rat brain. J Neurochem 28:929-934.
39. De Benedetti A, Harris AL. 1999. eIF4E expression in tumors: Its possible role in progression of malignancies. Int J Biochem Cell Biol 31:59-72.
40. De Gracia DJ. 2004. Acute and persistent protein synthesis inhibition following cerebral reperfusion. J Neurosci Res 77:771-776.
41. De Gracia DJ, Neumar RW, White BC, Krause GS. 1996. Global brain ischemia and reperfusion: Modifications in eukaryotic initiation factors associated with inhibition of translation initiation. J Neurochem 67:2005-2012.
42. De Gracia DJ, O'Neil BJ, Frisch C, Krause GS, Skjaerlund JM, et al. 1993. Studies of the protein synthesis system in the brain cortex during global ischemia and reperfusion. Resuscitation 25:161-170.
43. Deng J, Harding HP, Raught B, Gingras AC, Berlanga JJ, et al. 2002. Activation of GCN2 in UV-irradiated cells inhibits translation. Curr Biol 12:1279-1286.
44. Dever TE. 2002. Gene-specific regulation by general translation factors. Cell 108:545-556.
45. Dever TE, Feng L, Wek RC, Cigan AM, Donahue TF, et al. 1992. Phosphorylation of initiation factor 2α by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast. Cell 68:585-596.
46. Dhodda VK, Sailor KA, Bowen KK, Vemuganti R. 2004. Putative endogenous mediators of preconditioning-induced ischemic tolerance in rat brain identified by genomic and proteomic analysis. J Neurochem 89:73-89.
47. Dienel GA, Pulsinelli WA, Duffy TE. 1980. Regional protein synthesis in rat brain following acute hemispheric ischemia. J Neurochem 35:1216-1226.
48. Dmitriev SE, Terenin IM, Dunaevsky YE, Merrick WC, Shatsky IN. 2003. Assembly of 48S translation initiation complexes from purified components with mRNAs that have some base pairing within their 5'-untranslated regions. Mol Cell Biol 23:8925-8933.
49. Doutheil J, Althausen S, Gissel C, Paschen W. 1999. Activation of MYD116 (gadd34) expression following transient forebrain ischemia of rat: Implications for a role of disturbances of endoplasmic reticulum calcium homeostasis. Mol Brain Res 63:225-232.
50. Erdogdu G, Uto A, Hossmann KA. 1993. The effect of global ischemia and recirculation of rat brain on protein synthesis in vitro. Metab Brain Dis 8.
51. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, et al. 2004. MTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24:200-216.
52. Fraser CS, Lee JY, Mayeur GL, Bushell M, Doudna JA, et al. 2004. The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40S ribosomal subunit in vitro. J Biol Chem 279:8946-8956.
53. Fukuda TE, Adachi S, Kawashima I, Yoshiya I, Hashimoto PH. 1990. Immunohistochemical distribution of calciumactivated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus. J Comp Neurol 302:100-109.
54. Fukunaga R, Hunter T. 1997. MNK1, a new MAP kinaseactivated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J 16:1921-1933.
55. Fumagalli S, Thomas G. 2000. S6 phosphorylation and signal transduction. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 695-717.
56. Furuta S, Ohta S, Hatakeyama T, Nakamura K, Sakaki S. 1993. Recovery of protein synthesis in tolerance-induced hippocampal CA1 neurons after transient forebrain ischemia. Acta Neuropathol. 86:329-336.
57. García L, O'Loghlen A, Martín ME, Burda J, Salinas M. 2004a. Does phosphorylation of eukaryotic elongation factor eEF2 regulate protein synthesis in ischemic preconditioning? J Neurosci Res 77:292-298.
58. García L, Burda J, Hrehorovská M, Burda R, Martín ME, et al. 2004b. Ischemic preconditioning in the rat brain: Effect on the activity of several initiation factors, Akt and extracellular signal-regulated protein kinase phosphorylation, and GRP78 and GADD34 expression. J Neurochem 88:136-147.
59. Geballe AP, Sachs MS. 2000. Translational control by upstream open reading frames. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 595-614.
60. Gebauer F, Hentze MW. 2004. Molecular mechanisms of translational control. Nature Reviews 5:827-835.
61. Gilbert RW, Costain WJ, Blanchard M-E, Mullen KL, Currie RW, et al. 2003. DNA microarray analysis of hippocampal gene expression measured 12 h after hypoxia-ischemia in the mouse. J Cereb Blood Flow Metab 23:1195-1211.
62. Gingras A.-C, Raught B, Sonenberg N. 2004. mTOR signaling to translation. Curr Top Microbiol Immunol 279:169-198.
63. Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, et al. 2001. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 15:2852-2864.
64. Gingras AC, Raught B, Sonenberg N. 1999. eIF4 initiation factors: Effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68:913-963.
65. 2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 15:6179-6188.
66. Groisman I, Huang YS, Mendez R, Cao Q, Theurkauf W, et al. 2000. CPEB, maskin, and cyclin B1 mRNA at the mitotic apparatus. Implication for local translational control of cell division. Cell 103:435-447.
67. Harding HP, Calfon M, Urano F, Novoa I, Ron D. 2002. Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 18:575-599.
68. Harding HP, Zhang Y, Ron Z. 1999. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397:271-274.
69. de Haro C, Méndez R, Santoyo J. 1996. The eIF-2α kinases and the control of protein synthesis. FASEB J 10:1378-1387.
70. Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, et al. 1998. A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18:367-375.
71. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev 18:1926-1945.
72. Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Dodd RL, et al. 2003a. Oxidative damage to the endoplasmic reticulum is implicated in ischemic neuronal cell death. J Cereb Blood Flow Metab 23:1117-1128.
73. Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Chan PH. 2003b. Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death. J Cereb Blood Flow Metab 23:949-961.
74. Hellen CUT, Sarnow P. 2001. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15:1593-1612.
75. Hentze MW, Kuhn LC. 1996. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operate by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93:8175-8182.
76. Herbert TP, Tee AR, Proud CG. 2002. The extracellular signalregulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J Biol Chem 277:11591-11596.
77. Hershey JWB. 1991. Translational control in mammalian cells. Annu Rev Biochem 60:717-755.
78. Hershey JWB, Merrick WC. 2000. The pathway and mechanism of initiation of protein synthesis. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 33-88.
79. Hinnebusch AG. 1993. Gene-specific translational control of the yeast GCN4 gene by phosphorylation of eukaryotic initiation factor 2. Mol Microbiol 10:215-223.
80. Hinnebusch AG. 1997. Translational regulation of yeast GCN4. A window on factors that control initiator-tRNA binding to the ribosome. J Biol Chem 272:21661-21664.
81. Hinnebusch AG. 2000. Mechanism and regulation of initiator methionyl-tRNA binding to ribosomes. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 185-243.
82. Hodgman R, Tay J, Mendez R, Ritcher JD. 2001. CPEB phosphorylation and cytoplasmic polyadenylation are catalyzed by the kinase IAK1/Eg2 in maturing mouse oocytes. Development 128:2815-2822.
83. Horman S, Browne GJ, Krause U, Patel JV, Vertommen D, et al. 2002. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 12:1419-1423.
84. Hoshino S, Iai M, Kobayashi T, Uchida N, Katada T. 1999. The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-poly (A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein. J Biol Chem 274:16677-16680.
85. Hossmann KA. 1993. Disturbances of cerebral protein synthesis and ischemic cell death. Prog Brain Res 96:161-177.
86. Hou ST, MacManus JP. 2002. Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol 221:93-148.
87. Hu BR, Martone ME, Jones YZ, Liu CL. 2000. Protein aggregation after transient cerebral ischemia. J Neurosci 20:3191-3199.
88. Hu BR, Wieloch T. 1993. Stress-induced inhibition of protein synthesis initiation: Modulation of initiation factor 2 guanine nucleotide exchange factor activities following transient cerebral ischemia in the rat. J Neurosci 13:1830-1838.
89. Huang YS, Carson JH, Barbarese E, Ritcher JD. 2003. Facilitation of dendritic mRNA transport by CPEB. Genes Dev 17:638-653.
90. Huang YS, Jung MY, Sarkissian M, Richter JD. 2002. N-metyl-D-aspartate receptor signaling results in Aurora kinasecatalyzed CEBP phosphorylation and α-CaMKII mRNA polyadenylation at synapses. EMBO J 21:2139-2148.
91. Huber KM, Kayser MS, Bear MF. 2000. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288:1254-1257.
92. Hui DJ, Blasker CR, Merrick WC, Sen GC. 2003. Viral stressinducible protein p56 inhibits translation by blocking the interaction of eIF3 with ternary complex eIF2·GTP·MettRNAi. J Biol Chem 278:39477-39482.
93. Iadecola C. 1999. Mechanisms of cerebral ischemic damage. Cerebral Ischemia: Molecular and Cellular Pathophysiology. Walz W, editor. Totowa, NJ: Humana Press; pp. 3-32.
94. Jackson RJ. 2000. A comparative view of initiation site selection mechanisms. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 127-183.
95. Jan E, Kinzy TG, Sarnow P. 2003. Divergent tRNA-like element supports initiation, elongation, and termination of protein synthesis. Proc Natl Acad Sci USA 100:15410-15415.
96. s6K. EMBO J 16:3693-3704.
97. Jin K, Mao XO, Eshoo MW, Nagayama T, Minami M, et al. 2001. Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann Neurol 50:93-103.
98. Jin P, Zarnescu DC, Ceman S, Nakaoro M, Mowrey J, et al. 2004. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 7:113-117.
99. Jin P, Warren ST. 2003. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 28:152-158.
100. Job C, Eberwine J. 2001. Identification of sites for exponential translation in living dendrites. Proc Natl Acad Sci USA 98:13307-13042.
101. Johnstone O, Lasko P. 2004. Interaction with eIF5B is essential for Vasa function during development. Development 131:4167-4178.
102. Kaplan BB, Lavina ZS, Gioio AE. 2004. Subcellular compartmentation of neuronal protein synthesis: New insights into the biology of the neuron. Ann N Y Acad Sci 1018:244-254.
103. Kato H, Kogure K, Nakata N, Araki T, Itoyama Y. 1995. Facilitated recovery from postischemic supression of protein synthesis in the gerbil brain with ischemic tolerance. Brain Res Bull 36:205-208.
104. Kaufman RJ. 2000. The double-stranded RNA-activated protein kinase PKR. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 503-527.
105. Kaufman RJ. 2002. Orchestrating the unfolded protein response in health and disease. J Clin Invest 110:1389-1398.
106. Kawahara N, Wang Y, Mukasa A, Furuya K, Shimizu T, et al. 2004. Genome-wide gene expression analysis for induced ischemic tolerance and delayed neuronal death following transient global ischemia in rats. J Cereb Blood Flow Metab 24:212-223.
107. Kelleher RJ, Govindarajan A, Jung H-Y, Kang H, Tonegawa S. 2004a. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116:467-479.
108. Kelleher RJ, Govindarajan A, Tonegawa S. 2004b. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44:59-73.
109. Kimball SR, Mellor H, Flowers KM, Jefferson LS. 1996. Role of translation initiation factor eIF-2B in the regulation of protein synthesis in mammalian cells. Prog Nucleic Acid Res Mol Biol 54:165-196.
110. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, et al. 1990. "Ischemic tolerance" phenomenon found in the brain. Brain Res 528:21-24.
111. Knauf U, Tschopp C, Gram H. 2001. Negative regulation of protein translation by mitogen-activated protein kinaseinteracting kinases 1 and 2. Mol Cell Biol 21:5500-5511.
112. Kochetov AV, Ischenko IV, Vorobiev DG, Kel AE, Babenko VN, et al. 1998. Eukaryotic mRNAs encoding abundant and scarce proteins are statistically dissimilar in many structural features. FEBS Lett 440:351-355.
113. Kojima E, Takeuchi A, Haneda M, Yagi F, Hasegawa T, et al. 2003. The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress-elucidation by GADD34-deficient mice. FASEB J 17, 1573-1575.
114. Kozak M. 1989. The scanning model for translation: An update. J Cell Biol 108:229-241.
115. Kozak M. 1991. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870.
116. Kozak M. 1994. Determinants of translational fidelity and efficiency in vertebrate mRNAs. Biochimie 76:815-821.
117. Kozak M. 1999. Initiation of translation in prokaryotes and eukaryotes. Gene 234:187-208.
118. Kozak M. 2001. Constraints on reinitiation of translation in mammals. Nucleic Acids Res 29:5226-5232.
119. Krause GS, Tiffany BR. 1993. Suppression of protein synthesis in the reperfused brain. Stroke 24:747-756.
120. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik K. 2003. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274-1281.
121. Kristián T, Bo K, Siesjö MD. 1998. Calcium in ischemic cell death. Stroke 29:705-718.
122. Kumar R, Azam S, Sullivan JM, Owen C, Cavener DR, et al. 2001. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK. J Neurochem 77:1418-1421.
123. Kumar R, Krause GS, Yoshida H, Mori K, De Gracia DJ. 2003. Dysfunction of the unfolded protein response during global brain ischemia and reperfusion. J Cereb Blood Flow Metab 23:462-471.
124. Lawrence JC Jr, Brunn GJ. 2001. Insulin signaling and the control of PHAS-I phosphorylation. Prog Mol Subcell Biol 26:1-31.
125. Lee M-S, Kwon YT, Li M, Peng J, Friedlander RM, et al. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-368.
126. Lee JH, Pestova T, Shin B-S, Cao C, Choi SK, et al. 2002. Initiation factor eIF5B catalyzes second GTP-dependent step in eukaryotic translation initiation. Proc Natl Acad Sci USA 99:16689-16694.
127. Li PA, Howlett W, He QP, Miyashita H, Siddiqui M, et al. 1998. Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci Lett 247:17-20.
128. Lipton P. 1999. Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568.
129. 2+-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron 43:43-55.
130. Lu A, Tang Y, Ron R, Clark JF, Aronov BJ, Sharp FR. 2003. Genomics of periinfartation cortex after foal cerebral ischemia. J Cereb Blood Flow Metab 23:786-810.
131. Lynch M, Fitzgerald C, Johnston KA, Wang S, Schmidt EV. 2004. Activated eIF4E-binding proteins slows G1 progession and blocks transformation by c-myc without inhibiting cell growth. J Biol Chem 279:3327-3339.
132. MacManus JP, Graber T, Luebbert C, Preston E, Rasquinha I, et al. 2004. Translation-state analysis of gene expression in mouse brain after focal ischemia. J Cereb Blood Flow Metab 24:657-667.
133. Mahalingam M, Cooper GM. 2001. Phosphorylation of mammalian eIF4E by Mnk1 and Mnk2: tantalizing prospects for a role in translation. Prog Mol Subcell Biol 27:131-142.
134. Majumdar R, Bandyopadhyay A, Deng H, Maitra U. 2002. Phosphorylation of mammalian translation initiation factor 5 (eIF5) in vitro and in vivo. Nucleic Acids Res 30:1154-1162.
135. Marin P, Nastiuk KL, Daniel N, Girault JA, Czernik AJ, et al. 1997. Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J Neurosci 17:3445-3454.
136. Martín de la Vega C, Burda J, Nemethova M, Quevedo C, Alcázar A, et al. 2001a. Possible mechanisms involved in the down-regulation of translation during transient global ischemia in the rat brain. Biochem. J. 357:819-826.
137. Martín de la Vega C, Burda J, Salinas M. 2001b. Ischemiainduced inhibition of the initiation factor 2α phosphatase activity in the rat brain. NeuroReport 12:1021-1025.
138. Martín ME, Pérez MI, Redondo C, Álvarez MI, Salinas M, et al. 2000a. 4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers. Int J Biochem Cell Biol 32:633-642.
139. Martín ME, Muñoz F, Salinas M, Fando JL. 2000b. Ischemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem J 351:327-334.
140. Maruno M, Yanagihara T. 1990. Progressive loss of messenger RNA and delayed neuronal death following transient cerebral ischemia in gerbils. Neurosci Lett 115:155-160.
141. Mathews MB, Sonenberg N, Hershey JWB. 2000. Origins and targets of translational control. Translational control. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 1-29.
142. McKendrick L, Morley SJ, Pain VM, Jagus R, Joshi B. 2001. Phosphorylation of eukaryotic initiation factor 4E (eIF-4E) at Ser209 is not required for protein synthesis in vitro and in vivo. Eur J Biochem 268:5375-5385.
143. McLeod LE, Proud CG. 2002. ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signaling. FEBS Lett 531:448-452.
144. Meijer HA, Thomas AAM. 2002. Control of eukaryotic protein synthesis by upstream open reading frames in the 50-untranslated region of an mRNA. Biochem J 367:1-11.
145. Mendez R, Richter JD. 2001. Translational control by CPEB: A means to the end. Nature Rev Mol Cell Biol 2:521-529.
146. Mendez R, Wells D. 2002. Location, location, location: Translational control in development and neurobiology. Trends Cell Biol 12:407-409.
147. Mengesdorf T, Proud CG, Mies G, Paschen W. 2002. Mechanisms underlying suppression of protein synthesis induced by transient focal cerebral ischemia in mouse brain. Exp Neurol 177:538-546.
148. Merrick WC, Hershey JWB. 1996. The pathway and mechanisms of eukaryotic protein synthesis. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 31-69.
149. Merrick WC, Nyborg J. 2000. The protein biosynthesis elongation circle. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 89-125.
150. Meyuhas O. 2000. Synthesis of the translational apparatus is regulated at the translational level. Eur J Biochem 267:6321-6330.
151. Meyuhas O, Hornstein E. 2000. Translational control of TOP mRNAs. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 671-693.
152. Morimoto K, Brengman J, Yanagihara T. 1978. Further evaluation of polypeptide synthesis in cerebral anoxia, hypoxia, and ischemia. J Neurochem 31:1277-1282.
153. Morley SJ. 2001. The regulation of eIF4F during cell growth and cell death. Prog Mol Subcell Biol 27:1-37.
154. Morley SJ, Naegele S. 2002. Phosphorylation of eukaryotic initiation factor (eIF) 4E is not required for de novo protein synthesis following recovery from hypertonic stress in human kidney cells. J Biol Chem 277:32855-32859.
155. Mothe-Satney I, Yang D, Fadden P, Haystead TAJ, Lawrence JC Jr. 2000. Multiple mechanisms control phosphorylation of PHAS-I in five (S/T) P sites that govern translational repression. Mol Cell Biol 20:3558-3567.
156. Muñoz F, Martín ME, Manso-Tomico J, Berlanga J, Salinas M, et al. 2000. Ischemia-induced phosphorylation of initiation factor 2 in differentiated PC12 cells. Role for initiation factor 2 phosphatase. J Neurochem 75:2335-2345.
157. Muñoz F, Quevedo C, Martín ME, Alcázar A, Salinas M, et al. 1998. Increased activity of eukaryotic initiation factor 2B in PC12 cells in response to differentiation by nerve growth factor. J Neurochem 71:1905-1911.
158. Myers SJ, Huang Y, Genetta T, Dingledine R. 2004. Inhibition of glutamate receptor 2 translation by a polymorphic repeat sequence in the 50-untranslated leaders. J Neurosci 24:3489-3499.
159. Nairn AC, Matsushita M, Nastiuk K, Horiuchi A, Mitsui K-I, et al. 2001. Elongation factor-2 phosphorylation and the regulation of protein synthesis by calcium. Prog Mol Subcell Biol 27:91-129.
160. Neumar RW, De Gracia DJ, Konkoly LL, Khoury JI, White BC, et al. 1998. Calpain mediates eukaryotic initiation factor 4G degradation during global brain ischemia. J Cereb Blood Flow Metab 18:876-881.
161. Neumar RW, De Gracia DJ, White BC, McDermott PJ, Evans DR, et al. 1995. Eukaryotic initiation factor 4E degradation during brain ischemia. J Neurochem 65:1391-1394.
162. Neumar RW, Hagle SM, De Gracia DJ, Krause GS, White BC. 1996. Brain m-calpain autolysis during global cerebral ischemia. J Neurochem 66:421-424.
163. Nielsen KH, Szamecz B, Valasek L, Jivotovskaya A, Shin B-S, et al. 2004. Functions of eIF3 downstream of 48S assembly impact AUG recognition and GCN4 translational control. EMBO J 23:1166-1177.
164. Novoa I, Zeng H, Harding HP, Ron D. 2001. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α. J Cell Biol 153:1011-1022.
165. Nowak TS Jr, Fried RL, Lust WD, Passonneau JV. 1985. Changes in brain energy metabolism and protein synthesis following transient bilateral ischemia in the gerbil. J Neurochem 44:487-494.
166. Nowak TS Jr, Kiessling M. 1999. Reprogramming of gene expression after ischemia. Cerebral Ischemia. Molecular and cellular Pathology. Walz W, editor. Totowa, NJ: Humana Press; pp. 145-215.
167. O'Loghlen A, González VM, Piñeiro D, Pérez-Morgado MI, Salinas M, et al. 2004. Identification and molecular characterization of Mnk 1b, a splice variant of human MAP kinase-interacting kinase Mnk1. Exp Cell Res 299:343-355.
168. O'Loghlen A, Pérez-Morgado MI, Salinas M, Martín ME. 2003. Reversible inhibition of protein phosphatase 1 by hydrogen peroxide. Potential regulation of eIF2α phosphorylation in differentiated PC12 cells. Arch Biochem Biophys 417:194-202.
169. Ochoa S. 1983. Regulation of protein synthesis initiation in eukaryotes. Arch Biochem Biophys 223:325-349.
170. Ouellette AJ, Watson RK, Billmire K, Dygert MK, Ingwall JS. 1983. Protein synthesis in the cultured fetal mouse heart: effects of deprivation of oxygen and oxidizable substrate. Biochemistry 22:1201-1207.
171. Pain VM. 1996. Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 236:747-771.
172. Paradies MA, Steward O. 1997. Multiple subcellular mRNAs distribution patterns in neurons nonisotopic in situ hybridization analysis. J. Neurobiol. 33:473-493.
173. Paschen W. 2003. Shutdown of translation: Lethal or protective? Unfolded protein response versus apoptosis. J Cereb Blood Flow Metab 23:773-779.
174. Paschen W, Doutheil J. 1999. Disturbances of the functioning of endoplasmic reticulum: a key mechanism underlying neuronal cell injury? J Cereb Blood Flow Metab 19:1-18.
175. Paschen W, Aufenberg C, Hotop S, Mengesdorf T. 2003. Transient cerebral ischemia activates processing of xbp1 messenger RNA indicative of endoplasmic reticulum stress. J Cereb Blood Flow Metab 23:449-461.
176. Paschen W, Hayashi T, Saito A, Chan PH. 2004. GADD34 protein levels increase after transient ischemia in the cortex but not in the CA1 subfield: implications for post-ischemic recovery of protein synthesis in
177. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, et al. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402:615-622.
178. Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, et al. 1994. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature 371:762-767.
179. Pelletier J, Sonnerberg N. 1988. Internal initiation of translation eukaryotic mRNA directed by a sequence conserved from poliovirus RNA. Nature 334:320-325.
180. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, et al. 2004. S6K1/S6K2 Mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinasedependent S6 kinase pathway. Mol Cell Biol 24:3112-3124.
181. Pestova TV, Lomakin IB, Lee JH, Choi SK, Dever TE, et al. 2000. The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature 403:332-335.
182. Pinkstaff JK, Chapell SA, Mauro VO, Edelman GM, Krushel LA. 2001. Internal initiation of translation of five dendritically localized neuronal mRNAs. Proc Natl Acad Sci USA 98:2770-2775.
183. Preiss T, Hentze MW. 2003. Starting the protein synthesis machine: eukaryotic translation initiation. BioEssays 25:1201-1211.
184. Prevot D, Darlix JL, Ohlmann T. 2003. Conducting the initiation of protein synthesis: The role of eIF4G. Biol Cell 95:141-156.
185. Proud C. 2000. Control of the elongation phase of protein synthesis. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 719-739.
186. Proud CG. 1992. Protein phosphorylation in translational control. Curr Top Cell Regul 32:243-385.
187. Proud CG. 2001. Regulation of eukaryotic initiation factor eIF2B. Prog Mol Subcell Biol 26:95-114.
188. Proud CG. 2004. Role of mTOR signaling in the control of translation initiation and elongation by nutrients. Curr Top Microbiol Immunol 279:215-244.
189. Pyronnet S, Imataka H, Gingras AC, Fukunaga R, Hunter T, et al. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E. EMBO J 18:270-279.
190. Pyronnet S. 2000. Phosphorylation of the cap-binding protein eIF4E by the MAPK-activated protein kinase Mnk1. Biochem Pharmacol 60:1237-1243.
191. 2+/calmodulin-dependent protein kinase I. J Biol Chem 278:48570-48579.
192. Quevedo C, Alcázar A, Salinas M. 2000. Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J Biol Chem 275:19192-19197.
193. Quevedo C, Salinas M, Alcazar A. 2002. Regulation of capdependent translation by insulin-like growth factor-1 in neuronal cells. Biochem Biophys Res Commun 291:560-566.
194. Quevedo C, Salinas M, Alcázar A. 2003. Initiation factor 2B activity is regulatad by protein phosphatase 1, which is activated by the mitogen-activated protein kinase-dependent pathway in insulin-like growth factor 1-stimulated neuronal cells. J Biol Chem 278:16579-16586.
195. Raley-Susman KM, Lipton P. 1990a. In vitro ischemia and protein synthesis in the rat hippocampal slice: the role of calcium and NMDA receptor activation. Brain Res 515:27-38.
196. Raley-Susman KM, Lipton P. 1990b. NMDA receptor activation accelerates ischemic energy depletion in the hippocampal slice and the demonstration of a threshold for ischemic damage to protein synthesis. Neurosci Lett 110:118-123.
197. Raley-Susman KM, Murata J. 1995. Time course of protein changes following in vitro ischemia in the rat hippocampal slice. Brain Res 694:94-102.
198. Rami A. 2003. Ischemic neuronal death in the rat hippocampus: The calpain-calpastatin-caspase hypothesis. Neurobiol Dis 13:75-88.
199. Rami A, Agarwal R, Botez G, Winckler J. 2000. m-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res 866:299-312.
200. Raught B, Gingras AC, Gygi SP, Imataka H, Morino S, et al. 2000. Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J 19:434-444.
201. Raught B, Peiretti F, Gingras, A-C, Livingstone M, Shahbazian D, et al. 2004. Phosphorylation of eukaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 23:1761-1769.
202. Raught B, Gingras AC. 1999. eIF4E activity is regulated at multiple levels. Int J Biochem Cell Biol 31:43-57.
203. Read SJ, Parsons AA, Harrison DC, Philpott K, Kabnick K, et al. 2001. Stroke genomics: Approaches to identify, validate, and understand ischemic stroke gene expression. J Cereb Blood Flow Metab 21:755-778.
204. Richter JD, Theurkauf WE. 2001. The message is in the translation. Science 293:60-62.
205. Ritcher JD, Lorenz LJ. 2002. Selective translation of mRNAs at synapses. Curr Opin Neurobiol. 12:300-304.
206. Roads RE. 1999. Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 274:30337-30340.
207. Ron D, Harding HP. 2000. PERK and translational control by stress in the endoplasmic reticulum. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 547-560.
208. Rook MS, Lu M, Kosik KS. 2000. CaMKIIalpha 3'-untranslated region-directed mRNA translocation in living neurons: Visualization by GFP linkage. J Neurosci 20:6385-6393.
209. Rosenwald IB. 2004. The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 23:3230-3247.
210. Rouault TA, Harford JB. 2000. Translational control of ferritin synthesis. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 655-670.
211. Rutkowski DT, Kaufman RJ. 2004. A trip to the ER: Coping with stress. Trends Cell Biol 14:20-28.
212. Sachs A. 2000. Physical and functional interactions between the mRNA cap structure and the poly (A) tail. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 447-466.
213. Sarkissian M, Mendez R, Richter JD. 2004. Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase-3. Genes Dev 18:48-61.
214. Scheetz AJ, Nairn AC, Constantine-Paton M. 2000. NMDA receptor-mediated control of protein synthesis at developing synapses. Nat Neurosci 3:211-216.
215. Schmelzle T, Hall MN. 2000. TOR, a central controller of cell growth. Cell 103:253-262.
216. Schneider RJ. 2000. Translational control during heat shock. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 581-593.
217. Sharp FR, Aigang L, Yang T, Millhorn DE. 2000. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab 20:1011-1032.
218. Shelton SB, Johnson GW. 2004. Cyclin-dependent kinase-5 in neurodegeneration. J Neurohem 88:1313-1326.
219. Shi Y, Vattem KM, Sood R, An J, Liang J, et al. 1998. Identification and characterization of pancreatic eukaryotic initiation factor 2α-subunit kinase, PEK, involved in translational control. Mol Cell Biol 18:7499-7509.
220. Siesjö BK, Elmér E, Janelidze S, Keep M, Kristián T, et al. 1998. Role and mechanisms of secondary mitochondrial failure. Acta Neurochir Suppl (Wien) 73:7-13.
221. Stebbins-Boaz B, Cao Q, de Moor CH, Mendez R, Richter JD. 1999. Maskin is a CPEB-associated factor that transiently interacts with eIF4E. Mol Cell Biol 4:1017-1027.
222. Steward O, Schuman EM. 2001. Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 24:299-325.
223. Steward O, Schuman EM. 2003. Compartmentalized synthesis and degradation of proteins in neurons. Neuron 40:347-359.
224. Stolovich M, Tang H, Hornstein E, Levy G, Cohen R, et al. 2002. Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol-3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation. Mol Cell Biol 22:8101-8113.
225. Tanaka H, Grooms SY, Bennett VL, Zukin RS. 2000. The AMPAR subunit GluR2: still front and center-stage. Brain Res 886:190-207.
226. Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, et al. 2002. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 99:467-472.
227. Theurl I, Zoller H, Pbrist P, Datz C, Bachmann F, et al. 2004. Iron stimulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. J Infect Dis 190:819-825.
228. Thilmann R, Xie Y, Kleihues P, Kiessling M. 1986. Persistent inhibition of protein synthesis precedes delayed neuronal death in postischemic gerbil hippocampus. Acta Neuropathol 71:88-93.
229. Traugh JA. 2001. Insulin, phorbol ester, and serum regulate the elongation phase of protein synthesis. Prog Mol Subcell Biol 26:33-48.
230. Tsai L-H, Delalle I, Caviness VS Jr, Chae T, Harlow E. 1994. p35 is a neural-specific regulatory subunit of cyclindependent kinase 5. Nature 371:419-426.
231. Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R. 2004. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 24:6539-6549.
232. Velden van der AW, Thomas AAM. 1999. The role of the 50-untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31:87-106.
233. Vattem KM, Wek RC. 2004. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci USA 101:11269-11274.
234. Wang H, Iacoangeli A, Popp S, Muslimov IA, Imataka H, et al. 2002. Dendritic BC1 RNA: Functional role in regulation of translation initiation. J Neurosci 22:10232-10241.
235. Wang J, Liu S, Fu Y, Wang JH, Lu Y. 2003. Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nature Neurosci 6:1039-1047.
236. Wang X, Paulin FEM, Campbell LE, Gómez E, O'Brien K, et al. 2001a. Eukaryotic initiation factor 2B: Identification of multiple phosphorylation sites in the e-subunit and their functions in vivo. EMBO J 20:4349-4359.
237. Wang S, Lloyd RV, Hutzler MJ, Rosenwald IB, Safran MS, et al. 2001b. Expression of eukaryotic translation initiation factors 4E and 2α correlates with the progression of thyroid carcinoma. Thyroid 11:1101-1107.
238. Welch EM, Wang W, Peltz SW. 2000. Translation termination: It's not the end of the story. Translational control of gene expression. Sonenberg N, Hershey JWB, Mathews MB, editors. New York: Cold Spring Harbor Laboratory Press; pp. 467-485.
239. 14C) Leucine incorporation into brain proteins in gerbils after transient ischemia: Relationship to selective vulnerability of hippocampus. J Neurochem 56:789-796.
240. Woods YL, Cohen P, Becker W, Jakes R, Goedert M, et al. 2001. The kinase DYRK phosphorylates protein synthesis initiation factor eIF2Be at Ser 539 and the microtubuleassociated protein tau at Thr 212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355:609-615.
241. Wu L, Wells D, Tay J, Mendis D, Abbott MA, et al. 1998. CEBP-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of α-CAM-KII mRNA at synapses. Neuron 21:1129-1139.
242. Xie Y, Mies G, Hossmann KA. 1989. Ischemic threshold of brain protein synthesis after unilateral carotid artery occlusion in gerbils. Stroke 20:620-626.
243. Yaman I, Fernandez J, Liu H, Caprara M, Komar AA, et al. 2003. The zipper model of translational control: A small upstream ORF is the switch that controls structural remodeling of an mRNA leader. Cell 113:519-531.
244. Yan L, Nairn AC, Palfrey HC, Brady MJ. 2003. Glucose regulates EF-2 phosphorylation and protein translation by a protein phosphatase-2A-dependent mechanism in INS-1-derived 832/13 cells. J Biol Chem 278:18177-18183.
245. Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, et al. 2003. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112:317-327.
246. Zhang C, Siman R, Xu YA, Mills AM, Frederick JR, et al. 2002. Comparison of calpain and caspase activities in the adult rat brain after transient forebrain ischemia. Neurobiol Dis 10:289-305.